Complete Snibe MAGLUMI CLIA Assay Menu for UAE Laboratories

Chemiluminescence immunoassay (CLIA) has become an important part of routine and specialized laboratory testing because it combines automation, high analytical sensitivity, broad test menus and efficient turnaround. For laboratories in the UAE evaluating a CLIA platform, the available assay menu is often just as important as analyzer throughput or footprint.

Snibe’s MAGLUMI platform offers one of the broadest CLIA menus available from a single manufacturer. As of August 2026, Snibe’s official global website describes a broad MAGLUMI test menu with 278 parameters. The menu spans routine endocrine testing, fertility, tumor markers, infectious disease, cardiac biomarkers, autoimmune assays, bone metabolism, anemia, therapeutic drug monitoring and newer neurology biomarkers.

InstaMed supports laboratories in the UAE with Snibe MAGLUMI CLIA solutions, including analyzer selection, assay planning and technical support. The list below is designed as a practical reference for laboratories searching for a specific Snibe or MAGLUMI CLIA test.

Which MAGLUMI CLIA analyzers are available?

The MAGLUMI family includes compact and higher-throughput systems such as the MAGLUMI X3, X6, X8 and X10. Laboratories can select the analyzer according to workload, required turnaround time, available bench space and future menu expansion. For analyzer specifications, see InstaMed’s Snibe CLIA analyzers in UAE.

Snibe MAGLUMI CLIA test menu by clinical category

The following assay names are organized according to the clinical categories displayed on Snibe’s current global CLIA menu. Some analytes appear in more than one clinical category or format.

Thyroid

TSH (3rd Generation); Free T3; TRAb; Total T4; Tg (Thyroglobulin); TMA; Total T3; TGA (Anti-Tg); Reverse T3 (Rev T3); Free T4; Anti-TPO; T-Uptake.

Tumor Markers

AFP; CEA; Total PSA; Free PSA; CA 125; CA 15-3; CA 19-9; PAP; CA 50; CYFRA 21-1; CA 242; CA 72-4; NSE; S-100; SCCA; TPA-snibe; ProGRP; HE4; HER-2; PIVKA-II; AFP-L3%*; Pepsinogen I; Pepsinogen II; Gastrin-17; p2PSA*.

Fertility

FSH; LH; Total beta-HCG; PRL (Prolactin); Estradiol; Testosterone; Free Testosterone; DHEA-S; Progesterone; 17-OH Progesterone; AMH; SHBG; Androstenedione; PlGF; sFlt-1; Inhibin A*; Inhibin B*.

Autoimmune

ANA Screen; ENA Screen; Anti-dsDNA IgG; Anti-Sm IgG; Anti-Rib-P IgG; Anti-SS-B IgG; Anti-SS-A IgG; Anti-Jo-1 IgG; Anti-Scl-70 IgG; Anti-Centromeres IgG; Anti-Histones IgG; Anti-nRNP/Sm IgG; Anti-CCP; tTG IgA; tTG IgG; DGP IgA; DGP IgG; Anti-M2-3E IgG; Anti-TPO; TGA (Anti-Tg); TRAb; TMA; GAD 65; Anti-IA2; ICA; IAA (Anti-Insulin); Anti-MPO IgG; Anti-Cardiolipin IgG; Anti-Cardiolipin IgM; beta2-Glycoprotein I IgG; beta2-Glycoprotein I IgM; Anti-Ro-52 IgG; Anti-PM-Scl IgG; Anti-Nucleosome IgG; RF IgM*; RF IgG*; RF IgA*; RF Screen*; Anti-ZnT8; Anti-PR3 IgG; Anti-GBM IgG; Anti-Cardiolipin IgA; Anti-Cardiolipin*; beta2-Glycoprotein I IgA; beta2-Glycoprotein I.

Infectious Disease

HBsAg; Anti-HBs; HBeAg; Anti-HBe; Anti-HBc; Anti-HBc IgM; Anti-HCV; Anti-HAV; HAV IgM; HIV Ab/Ag Combi; Syphilis; Chagas; HTLV I+II; H. pylori IgG; H. pylori IgA; H. pylori IgM; Dengue Virus IgG; Dengue Virus NS1; Monkeypox Virus Ag; 2019-nCoV IgG; 2019-nCoV IgM; SARS-CoV-2 S-RBD IgG; SARS-CoV-2 NAb; SARS-CoV-2 Ag; Mycoplasma pneumoniae IgG; Mycoplasma pneumoniae IgM; Chlamydia pneumoniae IgG; Chlamydia pneumoniae IgM; HBV Pre-S1 Ag*; HEV IgG; HEV IgM; Dengue Virus IgM; Respiratory Syncytial Virus IgM*; Coxsackievirus B IgM*; Adenovirus IgM*; Influenza A Virus IgM*; Influenza B Virus IgM*; Legionella pneumophila IgM*; Human Parainfluenza Virus IgM*; H. pylori Ag*; HDV IgG*; HDV IgM*; Anti-HDV*; TB-IGRAs*; Zika Virus IgG*; Zika Virus IgM*; Zika Virus NS1*; Chlamydia trachomatis IgA*; Chlamydia trachomatis IgG*; HBsAg Confirmatory Test*; Borrelia IgG*; Borrelia IgM*.

Inflammation Monitoring

CRP; IL-6 (Interleukin 6); PCT (Procalcitonin); SAA (Serum Amyloid A); TNF-alpha; VEGF*; PCT (STAT-X format)*; CRP (STAT-X format)*; IgE.

TORCH

Toxoplasma IgG; Toxoplasma IgM; Rubella IgG; Rubella IgM; CMV IgG; CMV IgM; HSV-1/2 IgG; HSV-1/2 IgM; HSV-1 IgG; HSV-2 IgG; HSV-2 IgM; HSV-1 IgM; Toxoplasma IgG Avidity*; CMV IgG Avidity*; Parvovirus B19 IgG*; Parvovirus B19 IgM*.

Bone Metabolism

Calcitonin; 25-OH Vitamin D; beta-CTx; Osteocalcin; Intact PTH; Total P1NP; PTH (1-84); BAP*.

EBV

EBV VCA IgG; EBV VCA IgM; EBV VCA IgA; EBV EA IgG; EBV EA IgA; EBV NA IgG; EBV NA IgA.

Cardiac

CK-MB; Troponin I; Myoglobin; hs-cTnI; hs-CRP; H-FABP; NT-proBNP; BNP; D-Dimer; Lp-PLA2; MPO; HCY; sST2; hs-cTnI (STAT-X format)*; NT-proBNP (STAT-X format)*; Myoglobin (STAT-X format)*; D-Dimer (STAT-X format)*; GDF-15*; hs-cTnT*; H-FABP (STAT-X format)*; CK-MB (STAT-X format)*.

Prenatal Screening

AFP (Prenatal Screening); Free beta-HCG; Unconjugated Estriol; PAPP-A; Inhibin A*.

Hypertension

Direct Renin; Aldosterone; Angiotensin I; Angiotensin II; Cortisol; ACTH.

Glyco Metabolism / Diabetes

C-Peptide; Insulin; GAD 65; Anti-IA2; ICA; IAA (Anti-Insulin); Proinsulin; Glucagon*; Anti-ZnT8; Adiponectin (ADPN)*.

Coagulation Markers

D-Dimer; TM; tPAIC; TAT; PIC; FDP.

STAT-X

hs-cTnI*; Myoglobin*; PCT*; NT-proBNP*; D-Dimer*; CRP*; CK-MB*; H-FABP*.

Metabolism / Growth

IGF-I; GH (hGH); IGFBP-3.

Kidney Function

beta2-MG; Albumin; NGAL*.

Anemia

Vitamin B12; EPO; Ferritin; RBC Folate; Folate (FA); Anti-Intrinsic Factor*; Active B12*.

Hepatic Fibrosis

Hyaluronic Acid (HA); Collagen IV (C IV); Cholyglycine; PIIIP N-P; Laminin; GP73.

Drug Monitoring

Digoxin; CSA (Cyclosporine A); FK 506 (Tacrolimus); Sirolimus*; Everolimus*; Mycophenolic Acid*; Methotrexate*.

Veterinary Testing

cTSH; cTT4; cFT4; cCortisol; cACTH; cProgesterone; fProgesterone; fCortisol; fTT4; fACTH; fFT4*; fTSH*; cTLI*; fTLI*.

Neurology

NSE; S-100; beta-Amyloid (1-40) CSF*; beta-Amyloid (1-42) CSF*; Phospho-Tau (181P) CSF*; Total-Tau CSF*; beta-Amyloid (1-40) Plasma*; beta-Amyloid (1-42) Plasma*; Phospho-Tau (181P) Plasma*; Phospho-Tau (217P) Plasma*; NfL Plasma*.

* Asterisked items should be specifically reconfirmed for current product status, local registration and availability before a UAE availability claim is made.

Frequently searched MAGLUMI CLIA assays

• Thyroid testing: TSH, Free T3, Free T4, Total T3, Total T4, Anti-TPO, Anti-Tg/TGA, thyroglobulin and TRAb.
• Fertility and reproductive hormones: FSH, LH, beta-HCG, prolactin, estradiol, testosterone, progesterone, AMH, DHEA-S, SHBG and pre-eclampsia markers PlGF and sFlt-1.
• Tumor markers: AFP, CEA, PSA, free PSA, CA 125, CA 15-3, CA 19-9, HE4, ProGRP, NSE, CYFRA 21-1, SCCA, PIVKA-II and other specialized markers.
• Cardiac and emergency biomarkers: Troponin I, high-sensitivity cardiac troponin I, CK-MB, myoglobin, NT-proBNP, BNP, D-dimer, H-FABP and inflammatory markers.
• Bone and vitamin testing: 25-OH Vitamin D, PTH, PTH (1-84), osteocalcin, beta-CTx and total P1NP.
• Anemia and nutritional testing: Ferritin, Vitamin B12, folate, RBC folate, EPO and active B12.
• Infectious disease serology and antigen testing: hepatitis markers, HIV Ag/Ab, syphilis, dengue, SARS-CoV-2, H. pylori, HEV, HTLV and other infectious-disease assays.
• Autoimmune testing: ANA screen, ENA screen, anti-dsDNA, anti-CCP, celiac markers, antiphospholipid markers, ANCA-related antibodies and diabetes autoantibodies.

How should a laboratory choose its CLIA assay menu?

• Start with current test volume. Routine thyroid, fertility, vitamin D, tumor markers and infectious-disease assays often create the base workload.
• Identify tests currently referred to an outside laboratory. Bringing suitable tests in-house can improve turnaround time and laboratory control.
• Review low-volume but clinically important niche assays. A broad menu may allow a laboratory to expand without adding another immunoassay platform.
• Confirm local regulatory status, pack size, calibration frequency, controls, onboard stability and reagent shelf life before deciding on the final menu.
• Match analyzer throughput and reagent capacity to peak workload rather than only average daily volume.

Snibe CLIA support in Dubai, Abu Dhabi and across the UAE

InstaMed can support UAE laboratories evaluating Snibe MAGLUMI CLIA systems, assay menus and laboratory workflow requirements. Whether the requirement is a compact CLIA analyzer for a smaller laboratory or a broader menu for a high-volume facility, the starting point should be the actual workload and tests the laboratory wants to perform in-house.

For the current availability of a specific Snibe CLIA assay or MAGLUMI reagent in the UAE, contact InstaMed and share the required test names, expected monthly volume and preferred analyzer configuration.

Suggested visible FAQ section

How many CLIA assays does Snibe MAGLUMI offer?

Snibe’s official global website currently states a broad MAGLUMI CLIA menu with 278 parameters. Local registration and commercial availability should be confirmed for the UAE.

Does MAGLUMI include thyroid and fertility tests?

Yes. The global menu includes routine thyroid assays such as TSH, Free T3, Free T4, Total T3 and Total T4, as well as fertility markers including FSH, LH, beta-HCG, prolactin, estradiol, testosterone, progesterone and AMH.

Are tumor markers available on MAGLUMI?

The global menu includes a wide range of tumor markers such as AFP, CEA, PSA, free PSA, CA 125, CA 15-3, CA 19-9, HE4, ProGRP, NSE, SCCA and others.

Can InstaMed supply Snibe CLIA assays in the UAE?

InstaMed supports Snibe MAGLUMI solutions in the UAE. Availability of a specific assay should be confirmed against current registration, inventory and manufacturer status.

Which MAGLUMI analyzer should a laboratory choose?

The choice depends on workload, required throughput, assay mix, bench space and expected future growth. InstaMed can help assess the appropriate configuration.